You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Vasculitis

Tocilizumab for treating giant cell arteritis

  • Technology appraisal guidance
  • Reference number: TA518
  • Published:  18 April 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance: 1
  4. Invitation to participate

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 234 KB)

    Published:
    18 April 2018

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 368 KB)

    Published:
    08 March 2018
  • Committee papers (PDF 2.8 MB)

    Published:
    08 March 2018
  • Public committee slides (PDF 532 KB)

    Published:
    08 March 2018

Draft guidance: 1

  • Draft guidance: 1

  • Committee papers (PDF 13.93 MB)

    Published:
    05 December 2017
  • Public committee slides (PDF 1.19 MB)

    Published:
    05 December 2017
  • Appraisal consultation document (PDF 333 KB)

    Published:
    05 December 2017

Invitation to participate

  • Final scope (PDF 206 KB)

    Published:
    13 June 2017
  • Final matrix (PDF 250 KB)

    Published:
    13 June 2017
  • NICE's response to comments on the draft scope and provisional matrix (PDF 413 KB)

    Published:
    13 June 2017
  • Equality impact assessment (Scoping) (PDF 177 KB)

    Published:
    13 June 2017
  • Consultation document (PDF 333 KB)

    Published:
    05 December 2017
Back to top